Crapo in Omni est
This article was originally published in Scrip
Executive Summary
Omni Bio Pharmaceutical has announced that Dr James Crapo is to become its chief executive officer, effective 1 March. Dr Charles Dinarello, who has served as Omni Bio's acting CEO since its inception in March 2009, will become chief scientific officer and chief medical director. Dr Crapo has served on Omni Bio's scientific advisory board since March 2009. He is currently a professor at National Jewish Medical and Research Center and served as its executive vice-president of academic affairs and chairman of medicine from 1996-2004.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.